Regencell Bioscience Holdings Limited
Regulated industryPhysical productsDevelopment stageTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $6.33
- 52-Week Range
- $4.51 – $69.00
- Market Cap
- $3.37B
- P/E (TTM)
- —
- EPS (TTM)
- -0.01
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 3410.00
- PEG Ratio
- —
- Return on Equity
- -177.66%
- Return on Assets
- -84.97%
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Profit Margin
- 0.00%
- Current Ratio
- 1.42
- Debt/Equity
- 0.32
- Total Debt
- $386.30K
- Free Cash Flow
- —
- Revenue Growth
- —
- Earnings Growth
- —
- Enterprise Value
- $3.37B
Market Snapshot
About
Regencell Bioscience Holdings is a biotech company developing traditional Chinese medicine-based therapies for neurocognitive disorders. The company focuses on treating attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) through proprietary herbal formulations. Regencell conducts clinical research to validate the efficacy of traditional remedies using modern scientific methods.